The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results